NEW

The Joint Commission issues Sentinel Event Alert on optimizing medication safety with smart infusion pumps

A new Sentinel Event Alert from The Joint Commission, “Optimizing smart infusion pump safety with DERS,” describes how built-in dose error reduction software (DERS) can improve patient safety.

Hensler Bone Press Receives CE Certification

Hensler Surgical Technologies has announced its newly obtained CE mark for the Hensler Bone Press (HBP).

Healthmark Offers New Anti-Fatigue Mat

Healthmark Industries has introduced an Anti-Fatigue Mat to its Personal Protection Equipment (PPE) product line.

Cardinal Health awarded Strategic National Stockpile contract for PPE storage and distribution

With its expansive distribution network, Cardinal Health can provide rapid deployment and delivery of SNS product throughout the U.S. and its territories.

Aspen Medical Announces New President & CEO

Aspen Medical ProductsAspen Medical Products, LLC is excited to announce the appointment of seasoned orthopedic and spine executive, Jim Cloar, as the new President and CEO of Aspen Medical Products. Cloar will be succeeding Dan Williamson, founder of Aspen Medical Products, who will continue to be involved as a member of the Company’s Board of Directors and as a meaningful shareholder. Cloar comes with a rich background leading growth and expansion in orthopedic organizations focused on spine including DePuy, Medtronic, Biomet, and most recently, as President, Global Spine for ZimmerBiomet.

“I see Aspen Medical Products as the leader in spinal bracing products both within the US, and internationally, and welcome the opportunity to take this dynamic company from its history of innovation, quality and customer-focused product delivery to the next level of its evolution of growth and success,” Cloar stated upon accepting the position. “With the seasoned and dynamic executive team, well respected direct sales group, stellar relationships with key distributors, a culture of inclusion and commitment, and aggressive plans for organic growth through new product development and add-on acquisitions, the Company’s future is very bright which was extremely attractive to me.”

In mid-2019, Aspen was recapitalized by an affiliate of the New York based private equity firm, Cortec Group. Cortec invests in market-leading, middle-market specialty consumer, distribution, healthcare and specialty services and products businesses in partnership with owners and management teams who want to work with Cortec to drive growth and improve business fundamentals. “We remain pleased with our investment in Aspen Medical Products, which has performed well in a very difficult operating environment. Dan Williamson has been, and will continue to be, a great partner as he transitions to Board level involvement. We are excited to have someone with Jim Cloar’s experience and leadership capabilities as part of the team, and look forward to working with both of them to enable Aspen Medical Products to achieve continued success, while providing quality products to those who need them,” said Jeff Lipsitz, Co-President at Cortec.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X